Metabolic and GLP-1 Peptides
Retatrutide, tirzepatide, semaglutide and cagrilintide, supplied as vials and pens. Strengths spanning 2mg to 60mg.
Retatrutide
Tirzepatide
MOTS-c
SLU-PP-332
Semaglutide
AOD-9604
5-Amino-1MQ
Cagrilintide
Tesofensine
About Metabolic and GLP-1 Peptides
The incretin agonists
| Compound | Receptors | Code | Strengths here |
|---|---|---|---|
| Semaglutide | GLP-1 | , | 2mg, 5mg, 10mg |
| Tirzepatide | GIP, GLP-1 | LY3298176 | 5mg to 60mg |
| Retatrutide | GIP, GLP-1, glucagon | LY3437943 | 5mg to 40mg |
Cagrilintide is an amylin analogue, not an incretin agonist. We stock it by itself as well as combined within the blends.
What else is on this shelf?
SLU-PP-332 together with 5-Amino-1MQ are small molecules. AOD-9604 is a fragment of growth hormone. MOTS-c counts as a mitochondrial-derived peptide. Tesofensine works as a monoamine reuptake inhibitor.
What formats are these supplied in?
We carry retatrutide and tirzepatide both as vials and as pens in 20mg, 30mg and 40mg. The vial contains lyophilised powder that is reconstituted using bacteriostatic water; the pen comes already in solution.
Metabolic & GLP-1 questions
Which of these has the most published human data?
Semaglutide along with tirzepatide. Each has finished clinical programmes under its licensed brand name. The published human record for retatrutide stands at phase 2.
What is the difference between a pen and a vial?
A pen comes in solution. A vial comes as freeze-dried powder that is reconstituted ahead of use. The same compound, to the same specification.
Why does the price per milligram change with size?
Filling, labelling, packing and posting a larger vial costs less per milligram. That rate appears on every row.